Product Images Dexamethasone Sodium Phosphate

This is a prescription drug with National Drug Code (NDC) 0641-0367-21, meant for intravenous or intramuscular use only. It is Sodium Phosphate injection with a concentration of 10mg/mL, containing dexamethasone phosphate, which is equivalent to another drug. The drug is packaged in a 1 mL vial, manufactured by Hikma. The lot and expiry details are written but can't be deciphered due to errors. The drug needs to be protected from light.*

This is a description of a medication called Dexamethasone Sodium Phosphate Injection, USP. It is available in vials with 251 mL volume and contains Dexamethasone sodium phosphate equivalent to 10 mg of the same. It is meant for Intravenous or Intramuscular use only. Each vial contains sodium sulfite anhydrous 1.5 mg, Sodium citrate anhydrous 165 mg, and benzyl alcohol 1042 mg in water for injection. It should be kept covered in the carton and protected from light. The usual dosage is not mentioned. It should be stored at room temperature and should not be autoclaved or frozen. The manufacturer of this medication is Hikma US.*

This is a description of a medication called Dexamethasone Sodium Phosphate. It has an NDC code of 0641-6145-01 and is only available through a prescription. It is an injection solution with a concentration of 4mg/mL of dexamethasone phosphate equivalent. It is intended for intravenous, intramuscular, intralesional, intra-articular, or soft tissue use. The medication is sensitive to light, and as such, it is recommended to be protected from light. There are additional codes and characters, but they do not provide useful information.*

This is a prescription medicine with National Drug Code (NDC) of 0641-6145-25. It is an injection for intravenous, intramuscular, intralesional, intra-articular, or soft tissue use of Dexamethasone Sodium Phosphate for various medical applications. Each vial has a volume of 1 mL and it is light-sensitive requiring proper storage and handling. The usual recommended dosage is included, and the medicine must be stored within 20 to 25°C (68° to 77°F) and protected from freezing and high temperatures. The manufacturer is Hikma.*

This is a prescription drug with the NDC code 0641-6146-01. The usual dosage indication can be found in the package insert. The drug should be stored at a temperature between 20°C (68°F) and 25°C (77°F), protecting it from light. The drug is Sodium Phosphate Injection, USP and has 20mg per 5mL (4 mg/mL) of dexamethasone phosphate equivalent. It is manufactured by Hikma and it is intended for intravenous (IV), intramuscular (IM), intra-articular or soft tissue use. Its presentation is in a 5mL vial and the product code is 460-744-01. The remaining text consists of storage and handling information about the product.*

This is a prescription medicine with NDC code 0641-6146-25 containing dexamethasone sodium phosphate. The solution is intended for intravenous, intramuscular, intra-articular or soft tissue use, and each milliliter of the solution contains 4 mg of dexamethasone. It also contains other ingredients such as 1m sodium cilrate anhydrous, benzyl alcohol, and water for injection, and may require pH adjustment using sodium hydroxide and/or citric acid. The medication should be stored at controlled room temperature, protected from light, and should not be frozen or autoclaved. It is manufactured by Hikma and comes in 25 x 5 mL vials.*

This text provides product information including a GTIN (Global Trade Item Number), SN (Serial Number), EXP (Expiration date), and LOT (Lot Number).*